Human Papilloma Nosode
Generic Name: human papilloma nosode
Brand Names:
Papi Homo
PURPOSE: Human Papilloma Nosode - Itching in Pelvic Area
Overview
PURPOSE: Human Papilloma Nosode - Itching in Pelvic Area
Uses
USES: • For the temporary relief of symptoms including: • itching in pelvic area These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Dosage
DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a Physican or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.
Frequently Asked Questions
What is Human Papilloma Nosode used for?▼
USES: • For the temporary relief of symptoms including: • itching in pelvic area These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
What are the important warnings for Human Papilloma Nosode?▼
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a Physican or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.
Related Medications
Solesence Tm-s1
solesence tm-s1
Dosage form: POWDER. Active ingredients: TITANIUM DIOXIDE (1 kg/kg). Category: BULK INGREDIENT.
Berdazimer
berdazimer
11 DESCRIPTION ZELSUVMI (berdazimer) topical gel, 10.3%, a nitric oxide releasing agent, contains the drug substance berdazimer sodium, a white to off white powder with the chemical name poly[{[3-(methylamino)propyl]silasesquioxane}-co-{[3-(1-methyl-2-nitroso2-oxidohydrazin-1 yl)propyl]silasesquioxane}-co-silicate (1:3:6 x)], partially hydrolyzed (Si : OH ~ 10 : 5), and the following structural and empirical formula: Structural Formula: * Denotes shared oxygen atom between bonded constituents; r
Tovorafenib
tovorafenib
Kinase Inhibitor [EPC]
11 DESCRIPTION OJEMDA contains tovorafenib, a kinase inhibitor. Tovorafenib has the molecular formula C 17 H 12 Cl 2 F 3 N 7 O 2 S and a molecular weight of 506.29. The chemical name for tovorafenib is 6-amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide. Tovorafenib has the following chemical structure: It is a white to off-white powder.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.